Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
Warning: file_get_contents(http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=17885061&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 445
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Radiofrequency ablation in the management of liver metastases from breast cancer Sofocleous CT; Nascimento RG; Gonen M; Theodoulou M; Covey AM; Brody LA; Solomon SM; Thornton R; Fong Y; Getrajdman GI; Brown KTAJR Am J Roentgenol 2007[Oct]; 189 (4): 883-9OBJECTIVE: Systemic chemotherapy remains the standard treatment for patients with breast cancer hepatic metastases. Resection of metastases has survival advantages in a small percentage of selected patients. Radiofrequency ablation has been used in small numbers of selected patients. This small series was undertaken to review our experience with radiofrequency ablation in the management of patients with breast cancer hepatic metastases. CONCLUSION: Radiofrequency ablation of breast cancer hepatic metastases is safe and may be used to control hepatic deposits in patients with stable or no extrahepatic disease.|Adult[MESH]|Aged[MESH]|Breast Neoplasms/mortality/*surgery[MESH]|Catheter Ablation/*methods/statistics & numerical data[MESH]|Disease-Free Survival[MESH]|Female[MESH]|Humans[MESH]|Liver Neoplasms/mortality/*secondary/*surgery[MESH]|Middle Aged[MESH]|Neoplasm Recurrence, Local/mortality/*prevention & control[MESH]|New York/epidemiology[MESH]|Retrospective Studies[MESH]|Risk Assessment[MESH]|Risk Factors[MESH]|Survival Analysis[MESH]|Survival Rate[MESH]|Treatment Outcome[MESH] |
